| Dr Lynne Dunnington Peavey, AUD | |
|
5455 Meridian Mark Rd Suite 130, Pediatric Ear Nose & Throat Of Atlanta Pc, Atlanta, GA 30342-4277 | |
| (404) 255-2033 | |
| Not Available |
| Full Name | Dr Lynne Dunnington Peavey |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 14 Years |
| Location | 5455 Meridian Mark Rd Suite 130, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720321631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD001853 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stinson Mobile Aud Ga Llc | 6608110390 | 7 |
News Archive
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.
Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
University of Queensland (UQ) researchers are undertaking the largest and only longitudinal study of nurses and midwives ever attempted in the world.
› Verified 7 days ago
| Provider Name | Mobile Hearing Of Georgia, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265807358 PECOS PAC ID: 6103128178 Enrollment ID: O20160107001577 |
News Archive
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.
Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
University of Queensland (UQ) researchers are undertaking the largest and only longitudinal study of nurses and midwives ever attempted in the world.
› Verified 7 days ago
| Provider Name | Stinson Mobile Aud Ga Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669948642 PECOS PAC ID: 6608110390 Enrollment ID: O20181206002749 |
News Archive
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.
Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
University of Queensland (UQ) researchers are undertaking the largest and only longitudinal study of nurses and midwives ever attempted in the world.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynne Dunnington Peavey, AUD 25 E Knight Dr, Carrollton, GA 30116-7936 Ph: (770) 841-3698 | Dr Lynne Dunnington Peavey, AUD 5455 Meridian Mark Rd Suite 130, Pediatric Ear Nose & Throat Of Atlanta Pc, Atlanta, GA 30342-4277 Ph: (404) 255-2033 |
News Archive
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.
Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
University of Queensland (UQ) researchers are undertaking the largest and only longitudinal study of nurses and midwives ever attempted in the world.
› Verified 7 days ago
Buckhead Ear, Nose And Throat Audiologist Medicare: Medicare Enrolled Practice Location: 1800 Peachtree St Nw, Suite 700, Atlanta, GA 30309 Phone: 404-350-7966 Fax: 404-350-7968 | |
Dr. Debra Burnett Brewer, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne # A2334, Atlanta, GA 30322 Phone: 404-778-4441 Fax: 404-778-4295 | |
Beftu Teklu, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5673 Peachtree Dunwoody Rd Ste 150, Atlanta, GA 30342 Phone: 404-297-1785 | |
Margaret Jane Butler, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5461 Meridian Mark Rd Ste 130, Atlanta, GA 30342 Phone: 404-591-1884 | |
Patricia Beatriz Masso Maldonado, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5881 Glenridge Dr Ste 230, Atlanta, GA 30328 Phone: 404-943-0170 | |
Mr. Alan I Segal, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 960 Johnson Ferry Rd Ne, Ste 200, Atlanta, GA 30342 Phone: 404-943-0900 | |
Kelly Clinkscales Calkins, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 550 Peachtree St Ne, Ste 1640, Atlanta, GA 30308 Phone: 404-653-0830 Fax: 404-653-0832 |